{
    "nctId": "NCT00909818",
    "briefTitle": "Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients",
    "officialTitle": "Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients: a Randomized Phase III Trial, CIRRO (The Lundbeck Foundation Center for International Research in Radiation Oncology)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Carcinoma in Situ of the Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 976,
    "primaryOutcomeMeasure": "Grade 2 or 3 fibrosis 3 years after radiotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* operated with breast conserving strategy for:\n\n  1. invasive breast cancer, pT1-2, pN0-1mi, M0 OR\n  2. carcinoma in situ of the breast\n\nExclusion Criteria:\n\n* previous radiation of the breast/thorax\n* breast implants\n* pregnant/lactating\n* comorbidity which may hinder the patient in completing the therapy and complete follow up for 10 years",
    "sex": "FEMALE",
    "minimumAge": "41 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}